5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide
CAS: 1253584-84-7
Ref. 3D-DAC58484
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Información del producto
5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide (JNJ-635) is a small molecule inhibitor of the endocannabinoid metabolism. It prevents the degradation of anandamide and 2-arachidonoylglycerol (2AG). JNJ-635 has been shown to have antiinflammatory properties in vitro and in vivo, as well as anticonvulsant effects in mice. In addition, JNJ-635 has demonstrated neuroprotective effects in models of Alzheimer's disease and nonconvulsive seizures. These effects are mediated by the inhibition of microglial activation, which leads to reduced production of proinflammatory cytokines such as IL1β.
Propiedades químicas
Consulta técnica sobre: 3D-DAC58484 5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.